CRH and depressive symptom measurement: Particularly in the assessment of disturbed regulation of the hypothalamic-pituitary-adrenocortical (HPA) system, dexamethasone/corticotropin-releasing hormone (DEX/CRH) has been extensively investigated with a view towards the differential diagnosis of depression prior to the development of NIRS.